e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Translational studies in chronic repair and remodelling in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization
M. Funke, L. Knudsen, S. Matthieu, B. Fontaine, J. Chun, M. Ochs, A. Tager (Berne, Switzerland; Hannover, Germany; Boston, Indianapolis, La Jolla, United States Of America)
Source:
Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Session:
Translational studies in chronic repair and remodelling in the lung
Session type:
Oral Presentation
Number:
3331
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Funke, L. Knudsen, S. Matthieu, B. Fontaine, J. Chun, M. Ochs, A. Tager (Berne, Switzerland; Hannover, Germany; Boston, Indianapolis, La Jolla, United States Of America). The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization. Eur Respir J 2013; 42: Suppl. 57, 3331
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015
Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Promotion of pulmonary fibroblast migration by bile acid receptor through activation of TGF-ß1/p-Smad3 signaling pathway
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts
in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Cross-talk of circadian and immune system in neuropeptide S receptor 1 deficient mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Interaction of dietary fatty acids with obesity induced cytokines in primary human pulmonary fibroblasts
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Deletion of peroxiredoxin 6 potentiates OVA-induced asthma epithelial-mesenchymal transition through EGFR pathway
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Regulation of autophagy in amiodarone induced pulmonary fibrosis
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Transforming growth factor alpha expression in a transgenic mouse model impairs lung and diaphragm mechanics
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept